Market Cap (In USD)
1.65 Million
Revenue (In USD)
999.00
Net Income (In USD)
-79.67 Thousand
Avg. Volume
817.67 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.0024-0.0121
- PE
- -
- EPS
- -
- Beta Value
- -4.002
- ISIN
- US4053311092
- CUSIP
- 405331109
- CIK
- 1458631
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. William A. Hartman
- Employee Count
- -
- Website
- https://halberdcorporation.com
- Ipo Date
- 2012-09-25
- Details
- Halberd Corporation, a biotech company, develops treatments for neurodegenerative diseases. It offers treatments for post traumatic stress disorder/chronic traumatic encephalopathy, Alzheimer's and Parkinson's disease, cancer, blood-borne, and cerebrospinal fluid related diseases. The company was incorporated in 2009 and is based in Jackson Center, Pennsylvania.
More Stocks
-
BRRAYBarloworld Limited
BRRAY
-
CELLOCello World Limited
CELLO
-
SPXCY
-
4337
-
FUAPF
-
DXYZDestiny Tech100 Inc.
DXYZ
-
0396
-
TRU